{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:37:50Z","timestamp":1793659070741,"version":"4.5.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ajo.2023.05.008","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T02:24:11Z","timestamp":1683253451000},"page":"189-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Safety and Efficacy of Twice-Daily Pilocarpine HCl in Presbyopia: The Virgo Phase 3, Randomized, Double-Masked, Controlled Study"],"prefix":"10.1016","volume":"253","author":[{"given":"Shane","family":"Kannarr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif M.","family":"El-Harazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1024-6250","authenticated-orcid":false,"given":"Majid","family":"Moshirfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4208-6175","authenticated-orcid":false,"given":"Christopher","family":"Lievens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Lee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Peace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Safyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"S1","key":"10.1016\/j.ajo.2023.05.008_bib0001","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.3928\/1081597X-20210408-06","article-title":"Future trends in presbyopia correction","volume":"37","author":"Mercer","year":"2021","journal-title":"J Refract Surg"},{"key":"10.1016\/j.ajo.2023.05.008_bib0002","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ajo.2020.12.021","article-title":"Correlation of intraoperative optical coherence tomography of crystalline lens diameter, thickness, and volume with biometry and age","volume":"225","author":"Waring","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2023.05.008_bib0003","article-title":"Optometric clinical practice guideline\u2014care of the patient with presbyopia","year":"2011","journal-title":"American Optometric Association"},{"issue":"8","key":"10.1016\/j.ajo.2023.05.008_bib0004","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/OPX.0000000000001913","article-title":"Exploring the experience of living with and managing presbyopia","volume":"99","author":"Stokes","year":"2022","journal-title":"Optom Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2023.05.008_bib0005","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1167\/iovs.06-0586","article-title":"Multifocal spectacles increase variability in toe clearance and risk of tripping in the elderly","volume":"48","author":"Johnson","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.ajo.2023.05.008_bib0006","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1046\/j.1532-5415.2002.50502.x","article-title":"Multifocal glasses impair edge-contrast sensitivity and depth perception and increase the risk of falls in older people","volume":"50","author":"Lord","year":"2002","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"10.1016\/j.ajo.2023.05.008_bib0007","first-page":"1446","article-title":"Comparison of FDA safety and efficacy data for KAMRA and Raindrop corneal inlays","volume":"10","author":"Moshirfar","year":"2017","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2023.05.008_bib0008","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40123-017-0085-7","article-title":"A review of presbyopia treatment with corneal inlays","volume":"6","author":"Moarefi","year":"2017","journal-title":"Ophthalmol Ther."},{"issue":"1","key":"10.1016\/j.ajo.2023.05.008_bib0009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00006324-197501000-00002","article-title":"The depth-of-focus of the human eye for Snellen letters","volume":"52","author":"Tucker","year":"1975","journal-title":"Am J Optom Physiol Opt"},{"issue":"5","key":"10.1016\/j.ajo.2023.05.008_bib0010","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.exer.2010.02.005","article-title":"Topical and intravenous pilocarpine stimulated accommodation in anesthetized rhesus monkeys","volume":"90","author":"Wendt","year":"2010","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajo.2023.05.008_bib0011","unstructured":"Allergan, an AbbVie company. Highlights of prescribing informationVUITYTM (pilocarpine hydrochloride ophthalmic solution) 1.25%, for topical ophthalmic use. Accessed May 31, 2023. https:\/\/www.rxabbvie.com\/pdf\/vuity_pi.pdf"},{"issue":"4","key":"10.1016\/j.ajo.2023.05.008_bib0012","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jamaophthalmol.2022.0059","article-title":"Safety and efficacy of AGN-190584 in individuals with presbyopia: the GEMINI 1 phase 3 randomized clinical trial","volume":"140","author":"Waring GO","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2023.05.008_bib0013","series-title":"GEMINI 1 & 2 pooled phase 3 safety and efficacy: AGN-190584 primary and key secondary endpoints. Cataract Surgery \u201cTelling It Like It Is\u201d Meeting","author":"Waring","year":"2021"},{"issue":"1","key":"10.1016\/j.ajo.2023.05.008_bib0014","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s41687-021-00378-y","article-title":"Development of the Near Vision Presbyopia Task-based Questionnaire for use in evaluating the impact of presbyopia","volume":"5","author":"Shirneshan","year":"2021","journal-title":"J Patient Rep Outcomes"},{"issue":"4","key":"10.1016\/j.ajo.2023.05.008_bib0015","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s40123-021-00391-w","article-title":"Development of the Presbyopia Impact and Coping Questionnaire","volume":"10","author":"Johnson","year":"2021","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.ajo.2023.05.008_bib0016","series-title":"GEMINI 1 and 2 patient experience with the use of AGN-190584 (pilocarpine 1.25%) for presbyopia. 2021 American Academy of Optometry Meeting","author":"Brujic","year":"2021"},{"key":"10.1016\/j.ajo.2023.05.008_bib0017","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40662-016-0065-3","article-title":"Clinical outcomes of combined versus separate carbachol and brimonidine drops in correcting presbyopia","volume":"3","author":"Abdelkader","year":"2016","journal-title":"Eye Vis (Lond)"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423001952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423001952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:54:29Z","timestamp":1757598869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939423001952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":17,"alternative-id":["S0002939423001952"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2023.05.008","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Efficacy of Twice-Daily Pilocarpine HCl in Presbyopia: The Virgo Phase 3, Randomized, Double-Masked, Controlled Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2023.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}